Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects

The psychedelic psilocybin is being investigated for the treatment of depression and anxiety. Unclear is whether antidepressant treatments interact with psilocybin. The present study used a double‐blind, placebo‐controlled, crossover design with two experimental test sessions to investigate the resp...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical pharmacology and therapeutics Jg. 111; H. 4; S. 886 - 895
Hauptverfasser:	Becker, Anna M., Holze, Friederike, Grandinetti, Tanja, Klaiber, Aaron, Toedtli, Vanja E., Kolaczynska, Karolina E., Duthaler, Urs, Varghese, Nimmy, Eckert, Anne, Grünblatt, Edna, Liechti, Matthias E.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.04.2022
Schlagworte:	Antidepressive Agents - adverse effects Brain-Derived Neurotrophic Factor - genetics Citalopram - adverse effects Cross-Over Studies Double-Blind Method Escitalopram Healthy Volunteers Humans Psilocybin - adverse effects
ISSN:	0009-9236, 1532-6535, 1532-6535
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!